Literature DB >> 22550431

Head and neck cancer: an overview.

David Stepnick, David Gilpin.   

Abstract

Ablative surgery for malignancies of the upper aerodigestive tract is the most common reason why the reconstructive surgeon is called upon to reconstruct adult head and neck defects. An understanding of the pathophysiology and treatment of head and neck malignancy is vital to the reconstructive surgeon so that restoration of both form and function can be achieved. It is important to understand the behavior of cancers of each head and neck subsite, as staging and ultimately the treatment of tumors from each subsite is different. Historically, the standard treatment of head and neck cancer was surgery and/or primary radiation therapy with surgical salvage for failure. Beginning in the 1980s, advances in chemotherapy and concurrent delivery with radiation offered new options to standard surgical therapy. Over the past two decades, the concept of organ preservation using chemotherapy together with radiation therapy has been definitively established. Yet, even with the strides made over these two decades with chemoradiation, surgical treatment of head and neck cancer and reconstruction thereof will be an important treatment option for the foreseeable future. Therefore, the relationship between the extirpative and reconstructive surgeon is vital, and a clear understanding of the biology and behavior of head and neck malignancy is crucial to successful patient outcomes.

Entities:  

Keywords:  Head; cancer; neck

Year:  2010        PMID: 22550431      PMCID: PMC3324241          DOI: 10.1055/s-0030-1255328

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  10 in total

1.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.

Authors:  J L Lefebvre; D Chevalier; B Luboinski; A Kirkpatrick; L Collette; T Sahmoud
Journal:  J Natl Cancer Inst       Date:  1996-07-03       Impact factor: 13.506

3.  Definitive radiotherapy for squamous cell carcinoma of the base of tongue.

Authors:  William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; John W Werning; Douglas B Villaret
Journal:  Am J Clin Oncol       Date:  2006-02       Impact factor: 2.339

4.  Squamous cell carcinoma of the floor of mouth: a 20-year review.

Authors:  W L Hicks; T R Loree; R I Garcia; S Maamoun; D Marshall; J B Orner; V Y Bakamjian; D P Shedd
Journal:  Head Neck       Date:  1997-08       Impact factor: 3.147

Review 5.  Tumor-driven evolution of immunosuppressive networks during malignant progression.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Koji Arihiro
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

6.  Risk factors for distant metastases in head and neck squamous cell carcinoma.

Authors:  Werner Garavello; Alberto Ciardo; Roberto Spreafico; Renato Maria Gaini
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-07

Review 7.  Squamous cell carcinoma of the oropharynx and hypopharynx.

Authors:  Derrick T Lin; Seth M Cohen; George L Coppit; Brian B Burkey
Journal:  Otolaryngol Clin North Am       Date:  2005-02       Impact factor: 3.346

8.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Authors:  Rolando Herrero; Xavier Castellsagué; Michael Pawlita; Jolanta Lissowska; Frank Kee; Prabda Balaram; Thangarajan Rajkumar; Hema Sridhar; Barbara Rose; Javier Pintos; Leticia Fernández; Ali Idris; María José Sánchez; Adoración Nieto; Renato Talamini; Alessandra Tavani; F Xavier Bosch; Ulrich Reidel; Peter J F Snijders; Chris J L M Meijer; Raphael Viscidi; Nubia Muñoz; Silvia Franceschi
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

9.  (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.

Authors:  Stephan K Haerle; Klaus Strobel; Thomas F Hany; Daniel Sidler; Sandro J Stoeckli
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

10.  Carcinoma of the subglottic larynx.

Authors:  A R Shaha; J P Shah
Journal:  Am J Surg       Date:  1982-10       Impact factor: 2.565

  10 in total
  4 in total

1.  Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.

Authors:  Amrita Mukherjee; Howard W Wiener; Russell L Griffin; Carrie Lenneman; Arka Chatterjee; Lisle M Nabell; Cora E Lewis; Sadeep Shrestha
Journal:  Head Neck       Date:  2022-04-09       Impact factor: 3.821

2.  CRISPR-Cas9 HDR system enhances AQP1 gene expression.

Authors:  Zhimin Wang; Yaohe Wang; Songling Wang; Li-Rong Zhang; Na Zhang; Zhenguo Cheng; Qingshi Liu; Kelly J Shields; Baoli Hu; Michael J Passineau
Journal:  Oncotarget       Date:  2017-12-04

3.  Insonation of Systemically Delivered Cisplatin-Loaded Microbubbles Significantly Attenuates Nephrotoxicity of Chemotherapy in Experimental Models of Head and Neck Cancer.

Authors:  Hang-Kang Chen; Shu-Mei Zhang; Junn-Liang Chang; Hsin-Chien Chen; Yi-Chun Lin; Cheng-Ping Shih; Huey-Kang Sytwu; Mei-Cho Fang; Yuan-Yung Lin; Chao-Yin Kuo; Ai-Ho Liao; Yueng-Hsiang Chu; Chih-Hung Wang
Journal:  Cancers (Basel)       Date:  2018-09-05       Impact factor: 6.639

Review 4.  Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment.

Authors:  Cláudia Viegas; Daniela S M Pereira; Pedro Fonte
Journal:  Materials (Basel)       Date:  2022-03-11       Impact factor: 3.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.